This inventor holds 1 USPTO granted patent. Top assignee: Acadia Pharmaceuticals Inc.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Bruce Duane Coate: Innovator in Alzheimer's Disease Treatment
Introduction
Bruce Duane Coate is a notable inventor based in San Diego, CA. He has made significant contributions to the field of medicine, particularly in the treatment of Alzheimer's disease psychosis. His innovative approach has the potential to improve the quality of life for many individuals suffering from this condition.
Latest Patents
Coate holds a patent for "Pimavanserin alone or in combination for use in the treatment of Alzheimer's disease psychosis." This patent outlines methods for treating Alzheimer's disease psychosis, including administering pimavanserin or its pharmaceutically acceptable salts. The patent also details methods for reducing symptoms such as delusions, hallucinations, and agitated or aggressive behavior in individuals with dementia.
Career Highlights
Coate is associated with Acadia Pharmaceuticals Inc., where he continues to work on innovative solutions for neurological disorders. His dedication to research and development has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Coate has collaborated with notable colleagues, including James Randall Owen and Mark Donald Knowles. These partnerships have fostered a collaborative environment that enhances the development of effective treatments.
Conclusion
Bruce Duane Coate's work in the treatment of Alzheimer's disease psychosis exemplifies the impact of innovation in medicine. His contributions are paving the way for advancements that could significantly benefit patients and their families.